Raphaela joined Dr. Kelly’s group as a postdoctoral researcher in 2024. Originally from Brazil, she earned a Ph.D. in Molecular Pathology from the University of Brasilia. Skilled at translating clinical challenges into benchside experiments, she has a keen interest in specializing further in proteomics and metabolomics/lipidomics mass spectrometry-based workflows for clinical applications.
